trial · primary record
TAS6417
Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 285 |
| Primary completion | 2027-05-27 |
| Primary endpoint | Part A and B: The rate and severity of treatment emergent AEs |
| Registry ID | NCT05973773 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:40.478Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05973773
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.